Skip to main content
Jon Cuthbert Profile pIcture
Jon Cuthbert

Jon Cuthbert

GrafaFounder & COO

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.

Articles by Jon Cuthbert

Grafa

Werewolf Therapeutics explores strategic alternatives amid push for PREDATOR™ platform monetization

Werewolf Therapeutics (NASDAQ:HOWL), an innovative biopharmaceutical company developing "inducible" cytokines to treat cancer, today announced it has initiated a formal process to explore strategic alternatives.

Read more: Werewolf Therapeutics explores strategic alternatives amid push for PREDATOR™ platform monetization
Grafa

BioXcel Therapeutics advances toward home-use approval for IGALMI following 2025 financial results

BioXcel Therapeutics (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today reported its financial results for the fourth quarter and full year ended December 31, 2025.

Read more: BioXcel Therapeutics advances toward home-use approval for IGALMI following 2025 financial results
Grafa
Health

SBC Medical Group reports 117% surge in Q4 net income despite revenue headwinds

SBC Medical Group Holdings (NASDAQ:SBC), a leading Management Services Organization (MSO) for a diverse range of medical franchises, today announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025.

Read more: SBC Medical Group reports 117% surge in Q4 net income despite revenue headwinds